Filters
Other countries
Results: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
SLC24A5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 157 | 151 |
|
Invitae Oculocutaneous Albinism Panel Invitae United States | 28 | 22 |
|
PreventionGenetics, part of Exact Sciences United States | 39 | 33 |
|
Oculocutaneous Albinism (OCA) Panel PreventionGenetics, part of Exact Sciences United States | 18 | 15 |
|
Albinism oculocutaneous type VI (sequence analysis of SLC24A5 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Oculocutaneous albinism: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 7 | 6 |
|
CeGaT GmbH Germany | 9 | 9 |
|
CeGaT GmbH Germany | 10 | 8 |
|
Oculocutaneous albinism, Type 1, 2, 3, 4, 6, 7, NGS panel Department of Clinical Genetics Copenhagen University Hospital, Rigshospitalet Denmark | 7 | 6 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.